Alamar Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	1.83	0.52	0.31
Net Debt / Equity Ratio	-0.23	-0.07	0.35
Net Debt / EBITDA Ratio	-	-0.42	1.00
Net Debt / FCF Ratio	-	-0.19	0.80
Asset Turnover	-	0.51	0.17
Inventory Turnover	-	1.23	1.15
Quick Ratio	3.50	1.80	5.18
Current Ratio	5.88	3.99	6.43
Return on Equity (ROE)	-	-33.57%	-46.34%
Return on Assets (ROA)	-	-22.14%	-33.16%
Return on Invested Capital (ROIC)	-	-44.56%	-89.38%
Return on Capital Employed (ROCE)	-	-25.15%	-37.29%
Buyback Yield / Dilution	-	2.88%	-
Total Shareholder Return	-	2.88%	-

SEC Filings: 10-K · 10-Q